FDA classifies recall of Hologic’s implants for soft tissue as ‘most serious’

(Reuters) – The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic’s devices that are implanted in soft tissue such as breast tissue as “most serious”.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)